Turbocharging Peptide Drug Discoveries into
Life-Saving Treatments

Advancing the Discovery & Development of Peptide Drugs with Novel Screening, Chemistry, Formulation & CMC to Improve Permeability, Bioavailability & Efficacy Across All Diseases

Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson & Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy.

To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation of peptide discoveries through development and towards life-saving treatments.

Gathering industry leaders including Parabilis Medicines, Circle Pharma, Abbvie, Merck, Chugai Pharmaceuticals and many more, this is your premium forum to explore novel computational tools, optimize analytical assays, formulating cell-specific delivery methods and DMPK translatability towards clinical success of peptide therapies.

Join 100+ stakeholders from CEOs to Scientists in disciplines ranging from peptide drug discovery R&D, medicinal chemistry, pharmacology and formulation to accelerate this goldilocks modality from concept to commercialization.

This Summit will provide a deep learning experience for all peptide drug hunters and an opportunity to meet accomplished R&D leaders as well as share their scientific work as speakers or via poster presentations.

Tomi Sawyer, Maestro Therapeutics

Maestro Therapeutics logo

I see the summit as a great opportunity to meet other participants with a strong dedication to peptide therapeutics and who share the goal of oral peptide delivery.

Florian Foeger, Cyprumed

Cyprumed logo

As an investor, I look forward to meeting with the companies and thought leaders at the forefront of the peptide therapeutics space.

Alex Loftis, Vida Ventures

Vida Ventures

Download the Full Event Guide

  • Learn from 40+ Expert Speakers
  • NEW Two-Track Agenda covering Drug Discovery and Formulation & CMC
  • NEW Business Development & Investment Panel
  • 4 Deep-Dive Workshops to choose from
  • 25+ Data-Driven Case Studies to hear
Brochure for the 3rd Peptide-Based Therapeutics Summit 2026

What To Expect

100+

Peptide Experts in Attendance

40+

World-Class Speakers

25+

Data-Driven Case Studies

10+

Hours of Unrivalled Networking

4

Deep-Dive & Engaging Workshops

2

Brand-New Tracks of Content

Official Partners

Brochure for the 3rd Peptide-Based Therapeutics Summit 2026
Quick Download

Attending Companies Include

Abbvie
Merck Attendee Logo
Unnatural Products
Chugai Pharmaceuticals
Parabilis Medicines
Eli Lilly
Novo Nordisk logo
J and J
Astra Zeneca logo
Explore the Agenda
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Partner with Us
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Join Biopharma Experts
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.